Pathobiology of cancer metastasis: A short account

Cancer Cell International

Volumn 12, Issue , 2012, Pages

  Feller, Liviu ^a   Kramer, Beverley ^b   Lemmer, Johan ^c,d  

^a UNIVERSITY OF LIMPOPO   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cancer stem cells; Pre metastatic niche

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; WNT PROTEIN;

ANGIOGENESIS; BASEMENT MEMBRANE; BONE MARROW CELL; CANCER CELL; CANCER STEM CELL; CELL PROLIFERATION; CELL SURVIVAL; CYTOGENETICS; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HEMATOPOIETIC STEM CELL; MACROPHAGE; METASTASIS; MOLECULAR PATHOLOGY; PARACRINE SIGNALING; PATHOLOGY; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR GROWTH;

EID: 84861862446     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-12-24     Document Type: Review

References (40)

1. Feller L, Bouckaert M, Chikte UM, Wood NH, Khammissa RA, Meyerov R, Lemmer J. A short account of cancer-specifically in relation to squamous cell carcinoma. SADJ 2010, 65:322-324.
2. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006, 66:1883-1890. 10.1158/0008-5472.CAN-05-3153, 16488983.
3. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111. 10.1038/35102167, 11689955.
4. Croker AK, Allan AL. Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 2008, 12:374-390. 10.1111/j.1582-4934.2007.00211.x, 18182063.
5. Pienta KJ, Loberg R. The "emigration, migration, and immigration" of prostate cancer. Clin Prostate Cancer 2005, 4:24-30.
6. Feller L, Wood NH, Khammissa RA, Chikte UM, Essop R, Meyerov R, Lemmer J. Oral cancer-associated paraneoplastic syndromes. SADJ 2010, 65:424-426.
7. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344. 10.1158/0008-5472.CAN-06-3126, 16990346.
8. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009, 9:274-284. 10.1038/nrc2622, 19308067.
9. Fidler IJ, Radinsky R. Genetic control of cancer metastasis. J Natl Cancer Inst 1990, 82:166-168. 10.1093/jnci/82.3.166, 2296042.
10. Wels J, Kaplan RN, Rafii S, Lyden D. Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev 2008, 22:559-574. 10.1101/gad.1636908, 2731657, 18316475.
11. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008, 359:2814-2823. 10.1056/NEJMra0805239, 19109576.
12. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007, 8:341-352.
13. Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW. Cellular interactions in the tropism of prostate cancer to bone. Int J Cancer 2004, 110:497-503. 10.1002/ijc.20153, 15122581.
14. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549. 10.1016/S1535-6108(03)00132-6, 12842083.
15. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005, 115:44-55. 539194, 15630443.
16. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 2005, 173:10-20. 10.1097/01.ju.0000141582.15218.10, 15592017.
17. Wang J, Loberg R, Taichman RS. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 2006, 25:573-587.
18. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res 2006, 66:11089-11093. 10.1158/0008-5472.CAN-06-2407, 2952469, 17145848.
19. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827. 10.1038/nature04186, 2945882, 16341007.
20. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23:879-894. 10.1634/stemcells.2004-0342, 15888687.
21. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939. 10.1016/j.cell.2004.06.006, 15210113.
22. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008, 10:295-305. 10.1038/ncb1691, 18297062.
23. van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development 2009, 136:3205-3214. 10.1242/dev.033910, 19736321.
24. Li ZG, Yang J, Vazquez ES, Rose D, Vakar-Lopez F, Mathew P, Lopez A, Logothetis CJ, Lin SH, Navone NM. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone. Oncogene 2008, 27:596-603. 10.1038/sj.onc.1210694, 17700537.
25. Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005, 8:751-764. 10.1016/j.devcel.2005.02.017, 15866165.
26. Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 2007, 67:61-73. 10.1002/pros.20500, 17034033.
27. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454. 10.1038/nrc822, 12189386.
28. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008, 14:818-829. 10.1016/j.devcel.2008.05.009, 18539112.
29. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
30. Sun YX, Schneider A, Jung Y, Wang J, Dai J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, et al. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 2005, 20:318-329.
31. Kozlow W, Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 2005, 10:169-180. 10.1007/s10911-005-5399-8, 16025223.
32. Feller L, Lemmer J. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer 2008, 3:1. 10.1186/1750-9378-3-1, 2265259, 18208585.
33. Ouyang G, Wang Z, Fang X, Liu J, Yang CJ. Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells. Cell Mol Life Sci 2010, 67:2605-2618. 10.1007/s00018-010-0338-2, 20238234.
34. DiMeo TA, Anderson K, Phadke P, Fan C, Perou CM, Naber S, Kuperwasser C. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 2009, 69:5364-5373. 10.1158/0008-5472.CAN-08-4135, 2782448, 19549913.
35. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005, 5:744-749. 10.1038/nrc1694, 16148886.
36. Briegel KJ. Embryonic transcription factors in human breast cancer. IUBMB Life 2006, 58:123-132. 10.1080/15216540600686870, 16766379.
37. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902. 10.1038/nrc1232, 14737120.
38. Roato I, D'Amelio P, Gorassini E, Grimaldi A, Bonello L, Fiori C, Delsedime L, Tizzani A, De Libero A, Isaia G, et al. Osteoclasts are active in bone forming metastases of prostate cancer patients. PLoS One 2008, 3:e3627. 10.1371/journal.pone.0003627, 2574033, 18978943.
39. Levy J, Roodman GD. The role of bisphosphonates in multiple myeloma. Curr Hematol Malig Rep 2009, 4:108-112. 10.1007/s11899-009-0015-4, 20425422.
40. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003, 349:2483-2494. 10.1056/NEJMoa030847, 14695408.